The Vistria Group Acquires BioCare, Inc.
November 8, 2021
The Vistria Group has acquired BioCare, Inc., a Tempe-based specialty pharmaceutical distributor, specialty pharmacy and pharmaceutical logistics provider. The deal is Vistria’s first investment from its $2.68 billion Fund IV and aims to support BioCare’s growth — both organically and via acquisitions — to expand access to therapies for rare and orphan diseases.
- Buyers
- The Vistria Group
- Targets
- BioCare, Inc.
- Industry
- Healthcare Services
- Location
- Arizona, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Viatris to Acquire Pacira BioSciences for $1.65 Billion
October 9, 2026
Pharmaceuticals
Viatris agreed to acquire all outstanding shares of Pacira BioSciences for $36.50 per share in cash, valuing the company at approximately $1.65 billion. The acquisition adds Pacira’s marketed non-opioid pain therapies and commercial, market access, medical affairs, and R&D capabilities to Viatris; it is expected to close by the end of 2026, subject to customary conditions.
-
The Vistria Group Invests in Sandstone Care
June 28, 2022
Healthcare Services
The Vistria Group announced a growth investment in Sandstone Care, an adolescent and young adult mental and behavioral health treatment provider headquartered in Denver. The capital from Vistria's Fund IV will support Sandstone's expansion of existing campuses and growth into new markets to increase access to evidence-based care for teens and young adults.
-
The Vistria Group Acquires Beacon Specialized Living Services
March 28, 2022
Healthcare Services
The Vistria Group has acquired Beacon Specialized Living Services, a Kalamazoo-based provider of residential and support services for adults and children with severe mental illness and intellectual and developmental disabilities. The investment will provide capital to reinvest in care, fund innovation in Beacon's behavioral health model, and support geographic growth across several Midwest and East Coast states.
-
The Vistria Group and Excellere Partners Acquire SCA Pharmaceuticals
January 21, 2021
Pharmaceuticals
The Vistria Group and Excellere Partners purchased all outstanding equity interests of SCA Pharmaceuticals from Enhanced Healthcare Partners. SCA Pharma, an FDA-registered 503B outsourcing facility with sites in Windsor, Connecticut and Little Rock, Arkansas, will continue to be led by CEO Milton Boyer while the new owners plan to accelerate facility expansion, automation and growth.
-
General Atlantic Acquires Majority Stake in CareMetx; Vistria Reinvests
January 14, 2021
Healthcare Services
General Atlantic has entered a strategic growth partnership to become the majority owner of CareMetx, a Bethesda-based technology-enabled hub services company that supports patient access to specialty medications. Existing majority shareholder The Vistria Group is reinvesting and Marty Nesbitt (Vistria) will serve as CareMetx chairman; financial terms were not disclosed.
-
Vistria Group Acquires Mission Healthcare from HCAP Partners
December 16, 2020
Healthcare Services
Chicago-based private investment firm Vistria Group has acquired Mission Healthcare, a San Diego-based home health and hospice provider, in a transaction that represents an exit for HCAP Partners. Vistria’s investment will support Mission Healthcare’s continued growth across Southern California and other markets; terms were not disclosed.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.